Dr. Lori Wirth

Boston, USA

Dr. Lori Wirth is the Elizabeth and Michael Ruane Endowed Chair of Medical Oncology, Medical Director of the Center for Head and Neck Cancers at the Massachusetts General Hospital Cancer Center and an Associate Professor in Medicine at Harvard Medical School. Dr. Wirth is a leading authority in advanced thyroid cancer and head and neck oncology, with special expertise in combined modality therapy for cancers of the head and neck, immunotherapy and molecularly-targeted therapies for thyroid cancer., Dr. Wirth is the former Chairperson of the International Thyroid Oncology Group (ITOG), is a founding Executive Committee member of Thyroid International Recommendations Online (TIRO) and sits on a number of other national and international oncology committees, including the American Thyroid Association Guidelines Committee, the National Comprehensive Cancer Network’s Thyroid Cancer Committee and ABIM’s Medical Oncology Board Examination Committee.